A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B (Q73523468)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1 reference

V Carreño

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Zeuzem

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

U Hopf

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P Marcellin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

W G Cooksley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J Fevery

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Diago

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Reddy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Peters

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Rittweger

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Rakhit

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Pardo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

317-324

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

The treatment of chronic viral hepatitis

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B. The International Hepatitis Trial Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Efficacy of prolonged interferon-alpha treatment in chronic hepatitis B patients with HBeAb: comparison between 6 and 12 months of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Interleukin-12: potential clinical applications in the treatment and prevention of infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Experience with lamivudine against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Clinical experience with famciclovir against hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Multiple effects on peripheral hematology following administration of recombinant human interleukin 12 to nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Induction of interleukin-12 production in chronic hepatitis C virus infection correlates with the hepatocellular damage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Impaired interferon induction of human MxA protein in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Interleukin 12 suppresses autoantibody production by reversing helper T-cell phenotype in hepatitis B e antigen transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980078-1

7 January 2021

10.1016/S0168-8278(00)80078-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10707873%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference